The REPOSE (Reach for Equity in Pediatric Sleep Evaluation) Navigation Intervention
Testing a Strategy to Improve Diagnostic and Treatment Pathways for Children With Sleep-Disordered Breathing: the REPOSE Navigation Intervention
2 other identifiers
interventional
80
1 country
1
Brief Summary
This research study aims to find out the effect of REPOSE, a patient navigation intervention, on the receipt of equitable care among children with a broad range of socioeconomic and rural/urban status with Sleep Disordered Breathing (SDB). In the REPOSE intervention, a centralized patient navigator a) identifies and addresses dynamic individual barriers, b) provides resources and social support for parent-child dyads, and c) facilitates bidirectional SDB care coordination between clinical teams and parents to achieve evidence-based care. This study will evaluate the effects of the REPOSE intervention on SDB care delivery and clinical process outcomes for children with a broad range of socioeconomic and rural/urban status by reducing barriers and increasing self-efficacy among parents.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Feb 2026
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 5, 2025
CompletedFirst Posted
Study publicly available on registry
February 14, 2025
CompletedStudy Start
First participant enrolled
February 3, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 31, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
August 31, 2028
February 5, 2026
February 1, 2026
2.6 years
February 5, 2025
February 3, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Completion of specialist evaluation
Binary, evaluation of SDB by completion of specialist consultation (e.g., sleep medicine, otolaryngologist) per AAP guidelines.
up to 12months
Secondary Outcomes (10)
Time from referral to specialist consultation
12months
Completion of PSG
12months
Time to PSG
12months
Receipt of treatment
12months
Time to treatment
12months
- +5 more secondary outcomes
Other Outcomes (12)
Sociodemographic factors
Baseline (T0)
Clinical characteristics
Baseline (T0), 12months
Social Support
1-2 weeks following enrollment (T1), 6 months after enrollment (T2)
- +9 more other outcomes
Study Arms (2)
Reach for Equity in Pediatric Obstructive Sleep Evaluation (REPOSE)
OTHERREPOSE is a theory-based patient navigation intervention to address multilevel barriers to timely diagnosis and treatment of obstructive sleep-disordered breathing.
Usual Care
OTHERThe ordinary course of care.
Interventions
The REPOSE intervention consists of a centralized patient navigator who (1) identifies and addresses dynamic individual barriers, (2) provides support for parent-child dyads, and (3) facilitates bidirectional SDB care coordination between clinical teams and parents to achieve evidence-based care. The goals of the REPOSE intervention are to systematically address barriers to care, develop parental self-efficacy to enhance healthcare utilization (e.g., receipt of recommended care and adherence to evidence-based care), and to improve symptom severity and quality of life.
Usual care is defined by standard clinical care delivered without a protocolized intervention (e.g., the ordinary course of care).
Eligibility Criteria
You may qualify if:
- Parents or caregivers (18 and older) of children who were referred by any primary care for SDB evaluation with sleep medicine or pediatric otolaryngology
- Patients 2.00 to 11.99 years old
- Parents with a working phone who are willing to participate in the study for a 12-month period after enrollment
You may not qualify if:
- Patients already established with sleep medicine or otolaryngology which would bias ease of completing specialty evaluation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Medical University of South Carolina
Charleston, South Carolina, 29412, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Phayvanh Pecha, MD
Medical University of South Carolina
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor-Faculty
Study Record Dates
First Submitted
February 5, 2025
First Posted
February 14, 2025
Study Start
February 3, 2026
Primary Completion (Estimated)
August 31, 2028
Study Completion (Estimated)
August 31, 2028
Last Updated
February 5, 2026
Record last verified: 2026-02